Finerenone: A potential treatment for patients with chronic kidney disease and type 2 diabetes Mellitus

Review

Abstract: Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 i

Palabras claves:

cardiovascular diseases, Chronic kidney disease, Diabetic nephropathies, Finerenone

Autores:

D’marco L., Forquet C., Gandía L., Giménez-Civera E., Juan-García I., Panizo N., Puchades M.J., Reque J., Teruel J.L., Valmore Bermúdez

Fuentes:

scopus